Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
揭开层面：通过分析师见解探索Marinus Pharma
Throughout the last three months, 4 analysts have evaluated Marinus Pharma (NASDAQ:MRNS), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，有4位分析师对Marinus Pharma（纳斯达克股票代码：MRNS）进行了评估，提出了从看涨到看跌的不同观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $21.75, with a high estimate of $27.00 and a low estimate of $9.00. Observing a 141.67% increase, the current average has risen from the previous average price target of $9.00.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为21.75美元，最高估计为27.00美元，低估值为9.00美元。目前的平均价格上涨了141.67％，已从之前的平均目标价9.00美元上涨。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The standing of Marinus Pharma among financial experts...
通过对分析师近期...
登录免费看全文
登录/注册